Literature DB >> 27076176

TAE for HCC: When the Old Way is Better than the New Ones!!!

Giovanni Mauri1, Gianluca Maria Varano2, Franco Orsi2.   

Abstract

Mesh:

Year:  2016        PMID: 27076176     DOI: 10.1007/s00270-016-1340-3

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


× No keyword cloud information.
  8 in total

1.  Hepatic Arterial Embolization Using Cone Beam CT with Tumor Feeding Vessel Detection Software: Impact on Hepatocellular Carcinoma Response.

Authors:  F H Cornelis; A Borgheresi; E N Petre; E Santos; S B Solomon; K Brown
Journal:  Cardiovasc Intervent Radiol       Date:  2017-08-02       Impact factor: 2.740

2.  RETRACTED ARTICLE: Circular RNA ABCB10 promotes hepatocellular carcinoma progression by increasing HMG20A expression by sponging miR-670-3p.

Authors:  Yu Fu; Limin Cai; Xuexue Lei; Dunwei Wang
Journal:  Cancer Cell Int       Date:  2019-12-16       Impact factor: 5.722

3.  Treatment for Liver Tumor Using Combined Transarterial Embolization and Interaarterial Transfecting HIF-1α shRNA in a Rabbit VX2 Model.

Authors:  Chuangen Guo; Cheng Wang; Jingfeng Zhang; Xiao Chen
Journal:  Onco Targets Ther       Date:  2020-08-24       Impact factor: 4.147

4.  Degradable starch microspheres transarterial chemoembolization (DSMs-TACE) in patients with unresectable hepatocellular carcinoma (HCC): long-term results from a single-center 137-patient cohort prospective study.

Authors:  Antonio Orlacchio; Fabrizio Chegai; Silvia Roma; Stefano Merolla; Alessandra Bosa; Simona Francioso
Journal:  Radiol Med       Date:  2019-10-03       Impact factor: 3.469

Review 5.  New therapeutic approaches to metastatic gastroenteropancreatic neuroendocrine tumors: A glimpse into the future.

Authors:  Esther Una Cidon
Journal:  World J Gastrointest Oncol       Date:  2017-01-15

6.  Treatment of hepatic metastases from medullary thyroid cancer with transarterial embolisation.

Authors:  Peter Hughes; Nuala A Healy; Cliona Grant; J Mark Ryan
Journal:  Eur Radiol Exp       Date:  2017-06-29

7.  Transarterial chemoembolisation in patients with hepatocellular carcinoma: low-dose doxorubicin reduces post-embolisation syndrome without affecting survival-prospective interventional study.

Authors:  Ahmed A Bessar; Ahmed Farag; Sameh M Abdel Monem; Fady M Wadea; Shady E Shaker; Mahmoud Ahmed Ebada; Manar A Bessar
Journal:  Eur Radiol Exp       Date:  2021-03-02

8.  Circular RNA ABCB10 promotes hepatocellular carcinoma progression by increasing HMG20A expression by sponging miR-670-3p.

Authors:  Yu Fu; Limin Cai; Xuexue Lei; Dunwei Wang
Journal:  Cancer Cell Int       Date:  2019-12-16       Impact factor: 5.722

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.